Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure.

导出 OA

翻译打印收藏纠错

第一作者： T,Ueland

第一单位： Research Institute of Internal Medicine, Rikshospitalet, P.B. 4950 Nydalen, 0424 Oslo Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway.

作者： T,Ueland ^[1] ; J C,Holter ^[2] ; A R,Holten ^[3] ; K E,Müller ^[4] ; A,Lind ^[5] ; G K,Bekken ^[4] ; S,Dudman ^[2] ; P,Aukrust ^[6] ; A M,Dyrhol-Riise ^[7] ; L,Heggelund ^[8]

作者单位： Research Institute of Internal Medicine, Rikshospitalet, P.B. 4950 Nydalen, 0424 Oslo Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway. ^[1] Department of Microbiology, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. ^[2] Department of Acute Medicine, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. ^[3] Department of Internal Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway. ^[4] Department of Microbiology, Norway. ^[5] Research Institute of Internal Medicine, Rikshospitalet, P.B. 4950 Nydalen, 0424 Oslo Norway; Section of Clinical Immunology and Infectious, Diseases, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. ^[6] Department of Infectious Diseases, Oslo University Hospital, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. ^[7] Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway; Department of Internal Medicine, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway. ^[8]